Epigenetic mechanisms and the development of asthma

Slides:



Advertisements
Similar presentations
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Advertisements

Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma  Ronaldo P. Panganiban, BS, Yanli Wang, BS, Judie Howrylak, MD, PhD,
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Rachel L. Clifford, PhD, Meaghan J. Jones, PhD, Julia L
Defects of class-switch recombination
Laurent L'homme, PhD, David Dombrowicz, PhD 
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D
Klaus Bønnelykke, MD, PhD, Carole Ober, PhD 
Atopic dermatitis: Age and race do matter!
The role of air pollutants in atopic dermatitis
Disparities in allergic disease: Hypersensitivity and social disorders
The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology  Mate Kiss, Zsolt Czimmerer,
Social stress and asthma: The role of corticosteroid insensitivity
The nasal methylome and childhood atopic asthma
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Francine Kauffmann, MD, Florence Demenais, MD 
Is 9 more than 2 also in allergic airway inflammation?
Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma  Ronaldo P. Panganiban, BS, Yanli Wang, BS, Judie Howrylak, MD, PhD,
TNF-α–induced protein 3 (A20): The immunological rheostat
David J. Cousins, PhD, Joanne McDonald, BSc, Tak H. Lee, MD, ScD 
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Antimicrobial peptides and the skin immune defense system
The National Biome Initiative: An allergy perspective
DNA methylation and childhood asthma in the inner city
A network-based analysis of the late-phase reaction of the skin
Peter M. Wolfgram, MD, David B. Allen, MD 
Update on epigenetics in allergic disease
Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1  Huan Zhang, MD, PhD, Colm E. Nestor, PhD, Shuli Zhao, PhD,
Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma  Sean Whittaker  Journal of.
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Biologics and biomarkers for asthma, urticaria, and nasal polyposis
Reply Journal of Allergy and Clinical Immunology
Genome-Wide Epigenetics
Environmental determinants of allergy and asthma in early life
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
The role of histone deacetylases in asthma and allergic diseases
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Hong Ji, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
What is an “eosinophilic phenotype” of asthma?
Environmental epigenetics of asthma: An update
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
Update on glucocorticoid action and resistance
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Clinical consequences of defects in B-cell development
The discovery of IgE Journal of Allergy and Clinical Immunology
Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L
Sputum inflammatory cells from patients with allergic rhinitis and asthma have decreased inflammasome gene expression  Willie June Brickey, PhD, Neil.
Martin Brasholt, MD, Florent Baty, PhD, Hans Bisgaard, MD, DMSci 
TH9 immunodeficiency in patients with hyper-IgE syndrome
Not miR-ly small RNAs: Big potential for microRNAs in therapy
Endotoxin and the lung: Insight into the host-environment interaction
Asthma progression: Can we and should we measure it?
Macrolide antibiotics and asthma treatment
Cure of HIV infection: Is the long wait over?
Vitamin D in allergic disease: Shedding light on a complex problem
Immune pathomechanism of drug hypersensitivity reactions
Asthma: The past, future, environment, and costs
Environmental factors and eosinophilic esophagitis
Natural history of cow’s milk allergy
Itching as a systemic disease
Chitinases and chitinase-like proteins in TH2 inflammation and asthma
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Epigenetic mechanisms and the development of asthma Ivana V. Yang, PhD, David A. Schwartz, MD  Journal of Allergy and Clinical Immunology  Volume 130, Issue 6, Pages 1243-1255 (December 2012) DOI: 10.1016/j.jaci.2012.07.052 Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 An overview of epigenetic regulation of gene expression in asthmatic patients. Environmental exposures and dietary factors to which a subject is exposed in utero and postnatally influence epigenetic marks, which in turn regulate genes expression. Underlying genetic variation can regulate gene expression by affecting epigenetic marks or through other mechanisms (eg, alteration of transcription factor binding sites). Alterations in epigenetic marks have consequences on expression of key immune genes that regulate TH subtype cell skewing, which in turn leads to the development of disease. It is likely that distinct epigenomic profiles are associated with the development of allergic and nonallergic forms of asthma. ncRNA, Noncoding RNA; RORγt, retinoic acid–related orphan receptor; STAT, signal transducer and activator of transcription. Journal of Allergy and Clinical Immunology 2012 130, 1243-1255DOI: (10.1016/j.jaci.2012.07.052) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Effect of epigenetic marks (DNA methylation, histone modifications, and miRNAs) on gene expression. White circles denote unmethylated CpGs, and black circles denote methylated CpGs. Green circles refer to permissive histone modifications, and red circles indicate repressive histone marks. miRNAs can affect gene expression through either RNA degradation (perfect complementarity and binding) or inhibition of protein translation (imperfect complementarity and partial binding). Journal of Allergy and Clinical Immunology 2012 130, 1243-1255DOI: (10.1016/j.jaci.2012.07.052) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 An overview of the validation process for discovery of epigenetic marks associated with the development of asthma. Internal validation refers to confirmation in the same cohort by using a different technique and association of epigenetic marks with changes in gene expression, whereas external validation refers to validation of epigenetic marks in an independent cohort. Genome-wide analysis of gene expression is preferable to focused approaches because of complexities in the relationship of epigenetic marks and gene expression alterations. Journal of Allergy and Clinical Immunology 2012 130, 1243-1255DOI: (10.1016/j.jaci.2012.07.052) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions